Skip to main content
SpringerLink
Log in

Growth Factor Synergy in Angiogenesis

Growth Factor Interactions

  • Chapter
Retinal and Choroidal Angiogenesis

Abstract

The purpose of this chapter is to analyze existing data on the interactions of angiogenic growth factors in vivo and in vitro. It is shown that many growth factors act synergistically to elicit more potent angiogenic responses in endothelial cells. At the same time, some factors antagonize each other. Possible mechanisms of these phenomena are discussed. Anti-angiogenic strategies for cancer and retinopathies accounting for growth factor interactions are delineated with emphasis on combination therapy and targeting master regulators, such as HIF-1α and protein kinase CK2.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. R. F. Gariano, Cellular mechanisms in retinal vascular development, Prog. Ret. Eye Res. 22, 295-306 (2003).

    Article  CAS  Google Scholar 

  2. M. Saint-Geniez and P. A. D’Amore, Development and pathology of the hyaloid, choroidal and retinal vasculature, Int. J. Dev. Biol. 48, 1045-1058 (2004).

    Article  PubMed  Google Scholar 

  3. J. Folkman, Tumor angiogenesis: therapeutic implications, N. Engl. J. Med. 285, 1182-1186 (1971).

    Article  PubMed  CAS  Google Scholar 

  4. M. B. Grant, A. Afzal, P. Spoerri, H. Pan, L. C. Shaw, and R. N. Mames, The role of growth factors in the pathogenesis of diabetic retinopathy, Expert Opin. Investig. Drugs. 13, 1275-1293 (2004).

    Article  PubMed  CAS  Google Scholar 

  5. P. A. Campochiaro and S. F. Hackett, Ocular neovascularization: a valuable model system, Oncogene 22, 6537-6548 (2003).

    Article  PubMed  CAS  Google Scholar 

  6. S. Arii, A. Mori, S. Uchida, K. Fujimoto, Y. Shimada, and M. Imamura, Implication of vascular endothelial growth factor in the development and metastasis of human cancers, Hum. Cell. 12, 25-30 (1999).

    PubMed  CAS  Google Scholar 

  7. P. A. Campochiaro, Ocular neovascularisation and excessive vascular permeability, Expert Opin. Biol. Ther. 4, 1395-1402 (2004).

    Article  PubMed  CAS  Google Scholar 

  8. A. Saaristo, T. Karpanen, and K. Alitalo, Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis, Oncogene 19, 6122-6129 (2000).

    Article  PubMed  CAS  Google Scholar 

  9. M. Papetti and I. M. Herman, Mechanisms of normal and tumor-derived angiogenesis, Am. J. Physiol. Cell Physiol. 282, C947-C970 (2002).

    PubMed  CAS  Google Scholar 

  10. M. Streit and M. Detmar, Angiogenesis, lymphangiogenesis, and melanoma metastasis, Oncogene 22, 3172-3179 (2003).

    Article  PubMed  CAS  Google Scholar 

  11. C. R. Tait and P. F. Jones, Angiopoietins in tumours: the angiogenic switch, J. Pathol. 204, 1-10 (2004).

    Article  PubMed  CAS  Google Scholar 

  12. C. Costa, R. Soares, and F. Schmitt, Angiogenesis: now and then, APMIS 112, 402-412 (2004).

    Article  PubMed  Google Scholar 

  13. L. M. Ellis, Angiogenesis and its role in colorectal tumor and metastasis formation, Sem. Oncol. 31 (Suppl. 17), 3-9 (2004).

    Article  CAS  Google Scholar 

  14. T. Tammela, B. Enholm, K. Alitalo, and K. Paavonen, The biology of vascular endothelial growth factors, Cardiovasc. Res. 65, 550-563 (2005).

    Article  PubMed  CAS  Google Scholar 

  15. M. Grant, B. Russell, C. Fitzgerald, and T. J. Merimee, Insulin-like growth factors in vitreous. Studies in control and diabetic subjects with neovascularization, Diabetes 35, 416-420 (1986).

    Article  PubMed  CAS  Google Scholar 

  16. A. Sivalingam, J. Kenney, G. C. Brown, W. E. Benson, and L. Donoso, Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy, Arch. Ophthalmol. 108, 869-872 (1990).

    PubMed  CAS  Google Scholar 

  17. L. P. Aiello, R. L. Avery, P. G. Arrigg, B. A. Keyt, H. D. Jampel, S. T. Shah, L. R. Pasquale, H. Thieme, M. A. Iwamoto, J. E. Park, H. V. Nguyen, L. M. Aiello, N. Ferrara, and G. L. King, Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders, N. Engl. J. Med. 331, 1480-1487 (1994).

    Article  PubMed  CAS  Google Scholar 

  18. M. Boulton, Z. Gregor, D. McLeod, D. Charteris, J. Jarvis-Evans, P. Moriarty, A. Khaliq, D. Foreman, D. Allamby, and B. Bardsley, Intravitreal growth factors in proliferative diabetic retinopathy: correlation with neovascular activity and glycaemic management, Br. J. Ophthalmol. 81, 228-233 (1997).

    Article  PubMed  CAS  Google Scholar 

  19. A. Khaliq, D. Foreman, A. Ahmed, H. Weich, Z. Gregor, D. McLeod, and M. Boulton, Increased expression of placenta growth factor in proliferative diabetic retinopathy, Lab. Invest. 78, 109-116 (1998).

    PubMed  CAS  Google Scholar 

  20. H. Freyberger, M. Brocker, H. Yakut, J. Hammer, R. Effert, E. Schifferdecker, H. Schatz, and M. Derwahl, Increased levels of platelet-derived growth factor in vitreous fluid of patients with proliferative diabetic retinopathy, Exp. Clin. Endocrinol. Diabetes 108, 106-109 (2000).

    Article  PubMed  CAS  Google Scholar 

  21. A. Canton, R. Burgos, C. Hernandez, C. Mateo, R. M. Segura, J. Mesa, and R. Simo, Hepatocyte growth factor in vitreous and serum from patients with proliferative diabetic retinopathy, Br. J. Ophthalmol. 84, 732-735 (2000).

    Article  PubMed  CAS  Google Scholar 

  22. S. A. Schneeberger, L. M. Hjelmeland, R. P. Tucker, L. S. Morse, Vascular endothelial growth factor and fibroblast growth factor 5 are colocalized in vascular and avascular epiretinal membranes, Am. J. Ophthalmol. 124, 447-454 (1997).

    PubMed  CAS  Google Scholar 

  23. J. Cao, M. Kunz Mathews, D. S. McLeod, C. Merges, L. M. Hjelmeland, and G. A. Lutty, Angiogenic factors in human proliferative sickle cell retinopathy, Br. J. Ophthalmol. 83, 838-846 (1999).

    PubMed  CAS  Google Scholar 

  24. K. S. Spirin, M. Saghizadeh, S. L. Lewin, L. Zardi, M. C. Kenney, and A. V. Ljubimov, Basement membrane and growth factor gene expression in normal and diabetic human retinas, Curr. Eye Res. 18, 490-499 (1999).

    Article  PubMed  CAS  Google Scholar 

  25. J. S. Mohan, P. L. Lip, A. D. Blann, D. Bareford, and G. Y. Lip, The angiopoietin/Tie-2 system in proliferative sickle retinopathy: relation to vascular endothelial growth factor, its soluble receptor Flt-1 and von Willebrand factor, and to the effects of laser treatment, Br. J. Ophthalmol. 89, 815-819 (2005).

    Article  PubMed  CAS  Google Scholar 

  26. R. Castellon, H. K. Hamdi, I. Sacerio, A. M. Aoki, M. C. Kenney, and A. V. Ljubimov, Effects of angiogenic growth factor combinations on retinal endothelial cells, Exp. Eye Res. 74, 523-535 (2002).

    Article  PubMed  CAS  Google Scholar 

  27. M. S. Pepper, N. Ferrara, L. Orci, and R. Montesano, Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro, Biochem. Biophys. Res. Commun. 189, 824-831 (1992).

    Article  PubMed  CAS  Google Scholar 

  28. F. Goto, K. Goto, K. Weindel, and J. Folkman, Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels, Lab. Invest. 69, 508-517 (1993).

    PubMed  CAS  Google Scholar 

  29. R. B. Caldwell, M. Bartoli, M. A. Behzadian, A. E. B. El-Remessy, M. Al-Shabrawey, D. H. Platt, and R. W. Caldwell, Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives, Diabetes/Metabolism Res. Revs. 19, 442-455 (2003).

    Article  CAS  Google Scholar 

  30. A. N. Witmer, G. F. J. M. Vrensen, C. J. F. Van Noorden, and R. O. Schlingemann, Vascular endothelial growth factors and angiogenesis in eye disease, Prog. Ret. Eye Res. 22, 1-29 (2003).

    Article  CAS  Google Scholar 

  31. N. Ferrara, Vascular endothelial growth factor: basic science and clinical progress, Endocrine Revs. 25, 581-611 (2004).

    Article  CAS  Google Scholar 

  32. L. P. Aiello and Y. Hata, Molecular mechanisms of growth factor action in diabetic retinopathy, Curr. Opin. Endocrinol. Diabetes 6, 146-156 (1999).

    Article  CAS  Google Scholar 

  33. L. P. Aiello and J. S. Wong, Role of vascular endothelial growth factor in diabetic vascular complications, Kidney Int. 58 (Suppl. 77), 113-119 (2000).

    Article  Google Scholar 

  34. A. Das and P. G. McGuire, Retinal and choroidal angiogenesis: pathophysiology and strategies for inhibition, Prog. Ret. Eye Res. 22, 721-748 (2003).

    Article  CAS  Google Scholar 

  35. R. Bicknell and A. L. Harris, Novel angiogenic signaling pathways and vascular targets, Annu. Rev. Phrmacol. Toxicol. 44, 219-238 (2004).

    Article  CAS  Google Scholar 

  36. G. Tortora, R. Bianco, and G. Daniele, Strategies for multiple signaling inhibition, J. Chemother. 16 (Suppl. 4), 41-43 (2004).

    Google Scholar 

  37. P. Carmeliet, L. Moons, A. Luttun, V. Vincenti, V. Compernolle, M. De Mol, Y. Wu, F. Bono, L. Devy, H. Beck, D. Scholz, T. Acker, T. DiPalma, M. Dewerchin, A. Noel, I. Stalmans, A. Barra, S. Blacher, T. Vandendriessche, A. Ponten, U. Eriksson, K. H. Plate, J. M. Foidart, W. Schaper, D. S. Charnock-Jones, D. J. Hicklin, J. M. Herbert, D. Collen, and M. G. Persico, Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions, Nat. Med. 7, 575-583 (2001).

    Article  PubMed  CAS  Google Scholar 

  38. X. T. Sun, Y. T. Ding, X. G. Yan, L. Y. Wu, Q. Li, N. Cheng, Y. D. Qiu, and M. Y. Zhang, Angiogenic synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in an in vitro quantitative microcarrier-based three-dimensional fibrin angiogenesis system, World J. Gastroenterol. 10, 2524-2528 (2004).

    PubMed  CAS  Google Scholar 

  39. Y. Hata, S. L. Rook, and L. P. Aiello, Basic fibroblast growth factor induces expression of VEGF receptor KDR through a protein kinase C and p44/42 mitogen-activated protein kinase-dependent pathway, Diabetes 48, 1145-1155 (1999).

    Article  PubMed  CAS  Google Scholar 

  40. B. Nico, G. de Falco, A. Vacca, L. Roncali, and D. Ribatti, In vivo absence of synergism between fibroblast growth factor-2 and vascular endothelial growth factor, J. Hematother. Stem Cell Res. 10, 905-912 (2001).

    Article  PubMed  CAS  Google Scholar 

  41. L. E. H. Smith, W. Shen, C. Perruzzi, S. Soker, F. Kinose, X. Xu, G. Robinson, S. Driver, J. Bischoff, B. Zhang, J. M. Schaeffer, and D. R. Senger, Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor, Nat. Med. 5, 1390-1395 (1999).

    Article  PubMed  CAS  Google Scholar 

  42. R. O. Dull, J. Yuan, Y. S. Chang, J. Tarbell, R. K. Jain, and L. L. Munn, Kinetics of placenta growth factor/vascular endothelial growth factor synergy in endothelial hydraulic conductivity and proliferation, Microvasc. Res. 61, 203-210 (2001).

    Article  PubMed  CAS  Google Scholar 

  43. M. S. Pepper, S. J. Mandriota, M. Jeltsch, V. Kumar, and K. Alitalo, Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity, J. Cell. Physiol. 177, 439-452 (1998).

    Article  PubMed  CAS  Google Scholar 

  44. Y. G. Yao, H. S. Yang, Z. C. Cao, J. Danielsson, and E. J. Duh, Upregulation of placental growth factor by vascular endothelial growth factor via a post-transcriptional mechanism, FEBS Lett. 579, 1227-1234 (2005).

    Article  PubMed  CAS  Google Scholar 

  45. L. Xue and H. P. Greisler, Angiogenic effect of fibroblast growth factor-1 and vascular endothelial growth factor and their synergism in a novel in vitro quantitative fibrin-based 3-dimensional angiogenesis system, Surgery 132, 259-267 (2002).

    Article  PubMed  Google Scholar 

  46. E. Van Belle, B. Witzenbichler, D. Chen, M. Silver, L. Chang, R. Schwall, and J. M. Isner, Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor. The case for paracrine amplification of angiogenesis, Circulation 97, 381-390 (1998).

    PubMed  Google Scholar 

  47. M. E. Gerritsen, J. E. Tomlinson, C. Zlot, M. Ziman, and S. Hwang, Using gene expression profiling to identify the molecular basis of the synergistic actions of hepatocyte growth factor and vascular endothelial growth factor in human endothelial cells, Br. J. Pharmacol. 140, 595-610 (2003).

    Article  PubMed  CAS  Google Scholar 

  48. M. Beilmann, G. Birk, and M. C. Lenter, Human primary co-culture angiogenesis assay reveals additive stimulation and different angiogenic properties of VEGF and HGF, Cytokine 26, 178-185 (2004).

    Article  PubMed  CAS  Google Scholar 

  49. X. Xin, S. Yang, G. Ingle, C. Zlot, L. Rangell, J. Kowalski, R. Schwall, N. Ferrara, and M. E. Gerritsen, Hepatocyte growth factor enhances vascular endothelial growth factor-induced angiogenesis in vitro and in vivo, Am. J. Pathol. 158 (3), 1111-1120 (2001).

    Google Scholar 

  50. X. Xiao, J. Liu, and M. Sheng, Synergistic effect of estrogen and VEGF on the proliferation of hemangioma vascular endothelial cells, J. Pediatr. Surg. 39, 1107-1110 (2004).

    Article  PubMed  Google Scholar 

  51. I. Kryszek, A. Lange, P. Mottram, X. Alvarez, P. Cheng, M. Hogan, L. Moons, S. Wei, L. Zou, V. Machelon, D. Emilie, M. Terrassa, A. Lackner, T. J. Curiel, P. Carmeliet, and W. Zou, CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers, Cancer Res. 65, 465-472 (2005).

    Google Scholar 

  52. H. L. Brooks, Jr., S. Caballero, Jr., C. K. Newell, R. L. Steinmetz, D. Watson, M. S. Segal, J. K. Harrison, E. W. Scott, and M. B. Grant, Vitreous levels of vascular endothelial growth factor and stromal-derived factor 1 in patients with diabetic retinopathy and cystoid macular edema before and after intraocular injection of triamcinolone, Arch. Ophthalmol. 122, 1801-1807 (2004).

    Article  PubMed  CAS  Google Scholar 

  53. J. M. Butler, S. M. Guthrie, M. Koc, A. Afzal, S. Caballero, H. L. Brooks, R. N. Mames, M. S. Segal, M. B. Grant, and E. W. Scott, SDF-1 is both necessary and sufficient to promote proliferative retinopathy, J. Clin. Invest. 115, 86-93 (2005).

    Article  PubMed  CAS  Google Scholar 

  54. Y. Oshima, T. Deering, S. Oshima, H. Nambu, P. S. Reddy, M. Kaleko, S. Connelly, S. F. Hackett, and P. A. Campochiaro, Angiopoietin-2 enhances retinal vessel sensitivity to vascular endothelial growth factor, J. Cell. Physiol. 199, 412-417 (2004).

    Article  PubMed  CAS  Google Scholar 

  55. R. P. Visconti, C. D. Richardson, and T. N. Sato, Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF), Proc. Natl. Acad. Sci. USA 99, 8219-8224 (2002).

    Google Scholar 

  56. K. G. Shyu, H. Chang, and J. M. Isner, Synergistic effect of angiopoietin-1 and vascular endothelial growth factor on neoangiogenesis in hypercholesterolemic rabbit model with acute hindlimb ischemia, Life Sci. 73, 563-579 (2003).

    PubMed  CAS  Google Scholar 

  57. N. Arsic, L. Zentilin, S. Zacchigna, D. Santoro, G. Stanta, A. Salvi, G. Sinagra, and M. Giacca, Induction of functional neovascularization by combined VEGF and angiopoietin-1 gene transfer using AAV vectors, Mol. Ther. 7, 450-459 (2003).

    Article  PubMed  CAS  Google Scholar 

  58. H. Hutchings, M. Maitre-Boube, J. Tombran-Tink, and J. Plouët, Pigment epithelium-derived factor exerts opposite effects on endothelial cells of different phenotypes, Biochem. Biophys. Res. Commun. 294, 764-769 (2002).

    Article  PubMed  CAS  Google Scholar 

  59. M. Guan, C. P. Pang, H. F. Yam, K. F. Cheung, W. W. Liu, and Y. Lu, Inhibition of glioma invasion by overexpression of pigment epithelium-derived factor, Cancer Gene Ther. 11, 325-332 (2004).

    Article  PubMed  CAS  Google Scholar 

  60. E. J. Duh, H. S. Yang, I. Suzuma, M. Miyagi, E. Youngman, K. Mori, M. Katai, L. Yan, K. Suzuma, K. West, S. Davarya, P. Tong, P. Gehlbach, J. Pearlman, J. W. Crabb, L. P. Aiello, P. A. Campochiaro, and D. J. Zack, Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth, Invest. Ophthalmol. Vis. Sci. 43, 821-829 (2002).

    PubMed  Google Scholar 

  61. K. Takenaka, S. I. Yamagishi, Y. Jinnouchi, K. Nakamura, T. Matsui, and T. Imaizumi, Pigment epithelium-derived factor (PEDF)-induced apoptosis and inhibition of vascular endothelial growth factor (VEGF) expression in MG63 human osteosarcoma cells, Life Sci. 77 (25), 3231-3241 (2005).

    Article  PubMed  CAS  Google Scholar 

  62. C. K. Chan, L. N. Pham, J. Zhou, C. Spee, S. J. Ryan, and D. R. Hinton, Differential expression of pro- and antiangiogenic factors in mouse strain-dependent hypoxia-induced retinal neovascularization, Lab. Invest. 85, 721-733 (2005).

    Article  PubMed  CAS  Google Scholar 

  63. F. Ishikawa, K. Miyazono, U. Hellman, H. Drexler, C. Wernstedt, K. Hagiwara, K. Usuki, F. Takaku, W. Risau, and C. H. Heldin, Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor, Nature 338, 557-562 (1989).

    Article  PubMed  CAS  Google Scholar 

  64. W. Risau, H. Drexler, V. Mironov, A. Smits, A. Siegbahn, K. Funa, and C. H. Heldin, Platelet-derived growth factor is angiogenic in vivo, Growth Factors 7, 261-266 (1992).

    Article  PubMed  CAS  Google Scholar 

  65. X. Li, M. Tjwa, L. Moons, P. Fons, A. Noel, A. Ny, J. M. Zhou, J. Lennartsson, H. Li, A. Luttun, A. Ponten, L. Devy, A. Bouche, H. Oh, A. Manderveld, S. Blacher, D. Communi, P. Savi, F. Bono, M. Dewerchin, J. M. Foidart, M. Autiero, J. M. Herbert, D. Collen, C. H. Heldin, U. Eriksson, and P. Carmeliet, Revascularization of ischemic tissues by PDGF-CC via effects on endothelial cells and their progenitors, J. Clin. Invest. 115, 118-127 (2005).

    Article  PubMed  CAS  Google Scholar 

  66. X. Hao, A. Månsson-Broberg, T. Gustaffson, K. H. Grinnemo, P. Blomberg, A. J. Siddiqui, E. Wärdell, and C. Sylvén, Angiogenic effects of dual gene transfer of bFGF and PDGF-BB after myocardial infarction, Biochem. Biophys. Res. Commun. 315, 1058-1063 (2004).

    Article  PubMed  CAS  Google Scholar 

  67. F. De Marchis, D. Ribatti, C. Giampietri, A. Lentini, D. Faraone, M. Scoccianti, M. C. Capogrossi, and A. Facchiano, Platelet-derived growth factor inhibits basic fibroblast growth factor angiogenic properties in vitro and in vivo through its α receptor, Blood 99, 2045-2053 (2002).

    Article  PubMed  Google Scholar 

  68. J. L. Wilkinson-Berka, S. Babic, T. de Gooyer, A. W. Stitt, K. Jaworski, L. G. T. Ong, D. J. Kelly, and R. E. Gilbert, Inhibition of platelet-derived growth factor promotes pericyte loss and angiogenesis in ischemic retinopathy, Am. J. Pathol. 164, 1263-1273 (2004).

    PubMed  CAS  Google Scholar 

  69. H. Ozaki, N. Okamoto, S. Ortega, M. Chang, K. Ozaki, S. Sadda, M. A. Vinores, N. Derevjanik, D. J. Zack, C. Basilico, and P. A. Campochiaro, Basic fibroblast growth factor is neither necessary nor sufficient for the development of retinal eovascularization, Am. J. Pathol. 153, 757-765 (1998).

    PubMed  CAS  Google Scholar 

  70. S. J. Reich, J. Fosnot, A. Kuroki, W. Tang, X. Yang, A. M. Maguire, J. Bennett, and M. J. Tolentino, Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model, Mol. Vis. 9, 210-216 (2003).

    PubMed  CAS  Google Scholar 

  71. T. Tobe, S. Ortega, J. D. Luna, H. Ozaki, N. Okamoto, N. L. Derevjanik, S. A. Vinores, C. Basilico, and P. A. Campochiaro, Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model, Am. J. Pathol. 153, 1641-1646 (1998).

    PubMed  CAS  Google Scholar 

  72. L. N. Ramoshebi and U. Ripamonti, Osteogenic protein-1, a bone morphogenetic protein, induces angiogenesis in the chick chorioallantoic membrane and synergizes with basic fibroblast growth factor and transforming growth factor-β1, Anat. Rec. 259, 97-107 (2000).

    Article  PubMed  CAS  Google Scholar 

  73. Y. M. Lee, M. H. Bae, O. H. Lee, E. J. Moon, C. K. Moon, W. H. Kim, and K. W. Kim, Synergistic induction of in vivo angiogenesis by the combination of insulin-like growth factor-II and epidermal growth factor, Oncol. Rep. 12, 843-848 (2004).

    PubMed  CAS  Google Scholar 

  74. G. Thurston, Role of angiopoietins and Tie receptor tyrosine kinases in angiogenesis and lymphangiogenesis, Cell Tissue Res. 314, 61-68 (2003).

    Article  PubMed  CAS  Google Scholar 

  75. J. W. Distler, A. Hirth, M. Kurowska-Stolarska, R. E. Gay, S. Gay, and O. Distler, Angiogenic and angiostatic factors in the molecular control of angiogenesis, Q. J. Nucl. Med. 47, 149-161 (2003).

    PubMed  CAS  Google Scholar 

  76. C. D. Ley, M. W. B. Olsen, E. L. Lund, and P. E. G. Kristjansen, Angiogenic synergy of bFGF and VEGF is antagonized by angiopoietin-2 in a modified in vivo Matrigel assay, Microvasc. Res. 68, 161-168 (2004).

    Article  PubMed  CAS  Google Scholar 

  77. M. Onimaru, Y. Yonemitsu, M. Tanii, K. Nakagawa, I. Masaki, S. Okano, H. Ishibashi, K. Shirasuna, M. Hasegawa, and K. Sueishi, Fibroblast growth factor-2 gene transfer can stimulate hepatocyte growth factor expression irrespective of hypoxia-mediated downregulation in ischemic limbs, Circ. Res. 91, 923-930 (2002).

    Article  PubMed  CAS  Google Scholar 

  78. R. Castellon, S. Caballero, H. K. Hamdi, S. R. Atilano, A. M. Aoki, R. W. Tarnuzzer, M. C. Kenney, M. B. Grant, and A. V. Ljubimov, Effects of tenascin-C on normal and diabetic retinal endothelial cells in culture, Invest. Ophthalmol. Vis. Sci. 43, 2758-2766 (2002).

    PubMed  Google Scholar 

  79. K. Tanaka, N. Hiraiwa, H. Hashimoto, Y. Yamazaki, and M. Kusakabe, Tenascin-C regulates angiogenesis in tumor through the regulation of vascular endothelial growth factor expression, Int. J. Cancer 108, 31-40 (2004).

    Article  PubMed  CAS  Google Scholar 

  80. P. Nyberg, L. Xie, and R. Kalluri, Endogenous inhibitors of angiogenesis, Cancer Res. 65, 3967-3979 (2005).

    Article  PubMed  CAS  Google Scholar 

  81. J. Dixelius, L. Jacobsson, E. Genersch, S. Bohman, P. Ekblom, and L. Claesson-Welsh, Laminin-1 promotes angiogenesis in synergy with fibroblast growth factor by distinct regulation of the gene and protein expression profile in endothelial cells, J. Biol. Chem. 279, 23766-23772 (2004).

    Article  PubMed  CAS  Google Scholar 

  82. J. Sottile, Regulation of angiogenesis by extracellular matrix, Biochim. Biophys. Acta. 1654, 13-22 (2004).

    PubMed  CAS  Google Scholar 

  83. Y. Yokoyama, M. Dhanabal, A. W. Griffioen, V. P. Sukhatme, and S. Ramakrishnan, Synergy between angiostatin and endostatin: inhibition of ovarian cancer growth, Cancer Res. 60, 2190-2196 (2000).

    PubMed  CAS  Google Scholar 

  84. S. Filleur, A. Courtin, S. Ait-Si-Ali, J. Guglielmi, C. Merle, A. Harel-Bellan, P. Clézardin, and F. Cabon, SiRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growth, Cancer Res. 63, 3919-3922 (2003).

    PubMed  CAS  Google Scholar 

  85. M. Nozaki, E. Sakurai, B. J. Raisler, J. Z. Baffi, J. Witta, Y. Ogura, R. A. Brekken, E. H. Sage, B. K. Ambati, and J. Ambati, Loss of SPARC-mediated VEGFR-1 suppression after injury reveals a novel antiangiogenic activity of VEGF-A, J. Clin. Invest. 116, 422-429 (2006).

    Article  PubMed  CAS  Google Scholar 

  86. N. Ortéga, H. Hutchings, and J. Plouét, Signal relays in the VEGF system, Front. Biosci. 4, D141-D152 (1999).

    Article  PubMed  Google Scholar 

  87. S. Rakhit, S. Pyne, and N. J. Pyne, The platelet-derived growth factor receptor stimulation of p42/p44 mitogen-activated protein kinase in airway smooth muscle involves a G-protein-mediated tyrosine phosphorylation of Gab1, Mol. Pharmacol. 58, 413-420 (2000).

    PubMed  CAS  Google Scholar 

  88. M. A. Lawlor and P. Rotwein, Coordinate control of muscle cell survival by distinct insulin-like growth factor activated signaling pathways, J. Cell Biol. 151, 1131-1140 (2000).

    Article  PubMed  CAS  Google Scholar 

  89. J. Woolard, W. Y. Wang, H. S. Bevan, Y. Qiu, L. Morbidelli, R. O. Pritchard-Jones, T. G. Cui, M. Sugiono, E. Waine, R. Perrin, R. Foster, J. Digby-Bell, J. D. Shields, C. E. Whittles, R. E. Mushens, D. A. Gillatt, M. Ziche, S. J. Harper, and D. O. Bates, VEGF_165b, an inhibitory vascular endothelial growth factor splice variant. Mechanism of action, in vivo effect on angiogenesis and endogenous protein expression, Cancer Res. 64, 7822-7835 (2004).

    Article  PubMed  CAS  Google Scholar 

  90. J. Schoenfeld, K. Lessan, N. A. Johnson, D. S. Charnock-Jones, A. Evans, E. Vourvouhaki, L. Scott, R. Stephens, T. C. Freeman, S. A. Saidi, B. Tom, G. C. Weston, P. Rogers, S. K. Smith, and C. G. Print, Bioinformatic analysis of primary endothelial cell gene array data illustrated by the analysis of transcriptome changes in endothelial cells exposed to VEGF-A and PlGF, Angiogenesis 7, 143-156 (2004).

    Article  PubMed  CAS  Google Scholar 

  91. E. I. Cline, S. Bicciato, C. DiBello, and M. W. Lingen, Prediction of in vivo synergistic activity of antiangiogenic compounds by gene expression profiling, Cancer Res. 62, 7143-7148 (2002).

    PubMed  CAS  Google Scholar 

  92. R. L. Bilton and G. W. Booker, The subtle side to hypoxia inducible factor (HIFα ) regulation, Eur. J. Biochem. 270, 791-798 (2003).

    Article  PubMed  CAS  Google Scholar 

  93. B. D. Kelly, S. F. Hackett, K. Hirota, Y. Oshima, Z. Cai, S. Berg-Dixon, A. Rowan, Z. Yan, P. A. Campochiaro, and G. L. Semenza, Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1, Circ. Res. 93, 1074-1081 (2003).

    Article  PubMed  CAS  Google Scholar 

  94. T. H. Patel, H. Kimura, C. R. Weiss, G. L. Semenza, and L. V. Hofmann, Constitutively active HIF-1α improves perfusion and arterial remodeling in an endovascular model of limb ischemia, Cardiovasc. Res. 68 (1), 144-154 (2005).

    Article  PubMed  CAS  Google Scholar 

  95. B. Wang, Y. Zou, H. Li, H. Yan, J. S. Pan, and Z. L. Yuan, Genistein inhibited retinal neovascularization and expression of vascular endothelial growth factor and hypoxia inducible factor 1alpha in a mouse model of oxygen-induced retinopathy, J. Ocul. Pharmacol. Ther. 21, 107-113 (2005).

    Article  PubMed  Google Scholar 

  96. A. V. Ljubimov, S. Caballero, A. M. Aoki, L. A. Pinna, M. B. Grant, and R. Castellon, Involvement of protein kinase CK2 in angiogenesis and retinal neovascularization, Invest. Ophthalmol. Vis. Sci. 45, 4583-4591 (2004).

    Article  PubMed  Google Scholar 

  97. D. Mottet, S. P. Ruys, C. Demazy, M. Raes, and C. Michiels, Role for casein kinase 2 in the regulation of HIF-1 activity, Int. J. Cancer 117, 764-774 (2005).

    Article  PubMed  CAS  Google Scholar 

  98. A. Baldysiak-Figiel, G. K. Lang, J. Kampmeier, and G. E. Lang, Octreotide prevents growth factor-induced proliferation of bovine retinal endothelial cells under hypoxia, J. Endocrinol. 180, 417-424 (2004).

    Article  PubMed  CAS  Google Scholar 

  99. M. B. Grant, R. N. Mames, C. Fitzgerald, K. M. Hazariwala, R. Cooper-DeHoff, S. Caballero, and K. S. Estes, The efficacy of octreotide in the therapy of severe nonproliferative and early proliferative diabetic retinopathy: a randomized controlled study, Diabetes Care 23, 504-509 (2000).

    Article  PubMed  CAS  Google Scholar 

  100. A. A. Kramerov, M. Saghizadeh, H. Pan, A. Kabosova, M. Montenarh, K. Ahmed, J. S. Penn, C. K. Chan, D. R. Hinton, M. B. Grant, and A. V. Ljubimov, Expression of protein kinase CK2 in astroglial cells of normal and neovascularized retina, Am. J. Pathol. 168, 1722-1736 (2006).

    Article  PubMed  CAS  Google Scholar 

  101. N. Jo, C. Mailhos, M. Ju, E. Cheung, J. Bradley, K. Nishijima, G. S. Robinson, A. P. Adamis, and D. T. Shima, Inhibition of platelet-derived growth factor B signaling enhances the efficacy of anti-vascular endothelial growth factor therapy in multiple models of ocular neovascularization, Am. J. Pathol. 168, 2036-2053 (2006).

    Article  PubMed  CAS  Google Scholar 

  102. R. S. Kerbel, J. Yu, J. Tran, S. Man, A. Viloria-Petit, G. Klement, B. L. Coomber, and J. Rak, Possible mechanisms of acquired resistance to anti-angiogenic drugs: Implications for the use of combination therapy approaches, Cancer Metastasis Revs. 20, 79-86 (2001).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ophthalmology Research Laboratories, Cedars-Sinai Medical Center, and David Geffen School of Medicine, UCLA, Los Angeles, California

    Alexander V. Ljubimov

Authors
  1. Alexander V. Ljubimov
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Vanderbilt University School of Medicine, Nashville, TN, U.S.A

    J.S. Penn

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer Science+Business Media B.V.

About this chapter

Cite this chapter

Ljubimov, A.V. (2008). Growth Factor Synergy in Angiogenesis. In: Penn, J. (eds) Retinal and Choroidal Angiogenesis. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-6780-8_16

Download citation

Publish with us

Policies and ethics

Search

Navigation